|
|
|
Full Text: 
|
|
|
|
¿µ³²ÀÇ´ëÇмúÁö Vol.24_No.2 Suppl. P.S606-616, Dec. 2007
|
|
Original Article
|
|
Apoptosis Induced by 4-HPR on Human Stomach Adenocarcinoma Cell Line SNU1* |
|
|
|
Hyou Youn Kim¢Ó, Sang Woon Kim¢Ô, Seong Yong Kim¢Ó
|
¢ÓDepartment of Biochemistry and Molecular Biology,
¢ÔDepartment of General Surgery, College of Medicine, Yeungnam University, Daegu, Korea
|
|
|
|
Ã¥ÀÓÀúÀÚ£º±è¼º¿ë, ´ë±¸±¤¿ª½Ã ³²±¸ ´ë¸íµ¿ 317-1, ¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ »ýÈÇÐ?ºÐÀÚ»ý¹°Çб³½Ç
|
|
Tel: (053) 620-4343, Fax: (053) 654-6651
|
|
E-mail: seongyong@med.yu.ac.kr
|
|
December 30, 2007
|
|
|
|
Abstract
|
|
|
|
Purpose£ºRetinoids derived from vitamin A have diverse effects on development, morphogenesis, and homeostasis. They also have effects for prevention and treatment of cancers. In this study, the effect of N-(4-hydroxyphenyl) retinamide (4-HPR) on growth and/or proliferation of human gastric adenocarcinoma cell line SNU1 was investigated.
Materials and Methods£ºThe cytotoxic effect of 4-HPR was assessed by MTT assay. The apoptosis induced by 4-HPR was analyzed with cytoplasmic DNA Fragmentation, flow cytometry, and Western blot.
Results£º4-HPR induced cell death of SNU1. The cytoplasmic DNA fragmentation was increased time dependently after treatment of 4-HPR and the cells in the sub-G0/G1 fraction of flow cytometric analysis were also increased time dependently after treatment of 4-HPR. The cleavage of caspase 3 and PARP were detected after treatment of 4-HPR to SNU1.
The phosphorylations of Raf, ERK and AKT were induced by 4-HPR but after pre-treatment of MAPK inhibitor (PD98059) or PI-3 kinase inhibitor (LY294002) the 4-HPR-induced cytoplasmic DNA fragmentation, the cells in the sub-G0/G1 fraction fraction of flow cytometric analysis, and cleavage of caspase 3 and PARP were diminished in SNU1 cells.
Conclusion£ºThe results show that 4-HPR induces apoptosis of SNU1 and this 4-HPR- induced apoptosis may be mediated through ERK1/2 and PI3 kinase signaling pathways in SNU1.
*º» ¿¬±¸´Â 2005³âµµ °æÀϾàÇ°¢ß ¿¬±¸ºñÁö¿ø¿¡ ÀÇÇÏ¿© ÀÌ·ç¾îÁü.
|
|
|
|
Key Words: 4-HPR, SNU1, apoptosis.
|
|
|
|
References |
|
|
|
|
|
1. Costa A, Formelli F, Chiesa F, Decensi A, De Palo G, Veronesi U. Prospects of chemoprevention of human cancer with the synthetic retinoid fenretinide. Cancer Res 1994;54:2032-7.
|
|
|
2. Morris A, Passas J, Bateman W, Darley R. Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules. Cancer Immunol Immunother 1993; 37:112-8.
|
|
|
3. Sporn MB, Ballock RT, Heydemann A. Inhibition of the chondrocyte phenotype by retinoic acid involves upregulation of metallo- protease genes independent of TGF-beta. J Cell Physiol 1994;159:340-6.
|
|
|
4. Means AL, Gudas LJ. The roles of retinoids in vertebrate development. Annu Rev Biochem 1995;64:201-33.
|
|
|
5. Lotan R. Retinoids in cancer chemoprevention. FASEB J 1996;10:1031-9.
|
|
|
6. Lovat PE, Irving H, Malcolm AJ. 9-cis retinoic acid a better retinoid for the modulation of differentiation, proliferation and gene expression in human neuroblastoma. J Neurooncol 1997; 31:85-91.
|
|
|
7. Ohshima M, Ward JM, Wenk ML. Preventive and enhancing effects of retinoids on the development of naturally occurring tumors of skin, prostate gland, and endocrine pancreas in aged male ACI/segHapBR rats. J Natl Cancer Inst 1985;74:517-24.
|
|
|
8. Pollard M, Luckert PH, Sporn MB. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl) retinamide. Cancer Res 1991;51:3610-1.
|
|
|
9. Slawin K, Kadmon D, Park SH, Scardino PT, Anzano M, Sporn MB, Thompson TC. Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system. Cancer Res 1993;53:4461-5.
|
|
|
10. Ulukaya E, Wood EJ. Fenretinide and its relation to cancer. Cancer Treatment News 1999;25:229-35.
|
|
|
11. Modiano MR, Dalton WS, Lippman SM, Joffe L, Booth AR, Meyskens FL Jr. Phase II study of fenretinide (N-[4-hydroxyphenyl] retinamide) in advanced breast cancer and melanoma. Invest New Drugs 1990;8:317-9.
|
|
|
12. Cobleigh MA, Dowlatshahi K, Deutsch TA, Mehta RG, Moon RC, Minn F et al. Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer. J Clin Oncol 1993;11: 474-7.
|
|
|
13. Chodak GW, Rukstalis D, Kellman HM, Williams M. Phase II study of the retinoid analogue 4-HPR in men with carcinoma of the prostate. J Urol (Suppl) 1993;149:257A.
|
|
|
14. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM et al. Prevention of second primary tumors with isotretinoin in squamous- cell carcinoma of the head and neck. N Engl J Med 1990;323:795-801.
|
|
|
15. Cassano E, Coopmans de Yoldi G, Ferranti C, Costa A, Mascotti G, De Palo G et al. Mammographic patterns in breast cancer chemoprevention with fenretinide (4-HPR). Eur J Cancer 1993;29A:2161-3.
|
|
|
16. Pienta KJ, Esper PS, Zwas F, Krzeminski R, Flaherty LE. Phase II chemoprevention trial of oral fenretinide in patients at risk for adenocarcinoma of the prostate. Am J Clin Oncol 1997;20:36-9.
|
|
|
17. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-6.
|
|
|
18. DiPietrantonio AM, Hsieh TC, Olson SC, Wu JM. Altered expression of the G1/S checkpoint regulators (cyclin D1, cdk4, pRB) and transient modulation of poly(ADP-ribose) polymerase and ceramide level changes by fenretinide N-(4-hydroxyphenyl) retinamide, 4-HPR) in human promyelocytic leukemic cells. Int J Cancer 1998;78:53-61.
|
|
|
19. Delia D, Aiello A, Meroni L, Nicolini M, Reed JC, Pierotti MA. Role of antioxidants and intracellular free radicals in retinamide-induced cell death. Carcinogenesis 1997;18:943-8.
|
|
|
20. Suzuki S, Higuchi M, Proske RJ, Oridate N, Hong WK, Lotan R. Implication of mitochondria- derived reactive oxygen species, cytochrome C and caspase-3 in N-(4-hydroxyphenyl) retinamide-induced apoptosis in cervical carcinoma cells. Oncogene 1999;18:6380-7.
|
|
|
21. Chen YR, Zhou G, Tan TH. C-Jun N-terminal kinase modulates apoptotic signaling induced by N-(4-hydroxyphenyl) retinamide. Mol Pharmacol 1999;56:1271-9.
|
|
|
22. Fang JY, Xiao SD. Effect of trans-retinoic acid and folic acid on apoptosis in human gastric cancer cell lines MKN 45 and MKN 28. J Gastroenterol 1998;33:656-61.
|
|
|
23. Liu G, Wu M, Levi G, Ferrari N. Inhibition of cancer cell growth by all-trans-retinoic acid and its analog N-(4-hydroxyphenyl) retinamide: A possible mechanism of action via regulation of retinoid receptors expression. Int J Cancer 1998;78:248-54.
|
|
|
24. Wu JM, DiPietrantonio AM, Hsieh T-C. Mechanism of fenretinide (4-HPR) induced cell death. Apoptosis 2001;6:377-88.
|
|
|
25. Voelkel-Johnson C, Entingh AJ, Wold WS, Gooding LR, Laster SM. Activation of intracellular proteases is an early event in TNF-induced apoptosis. J Immunol 1995;154: 1707-16.
|
|
|
26. Widmann C, Gerwins P, Johnson NL, Jarpe MB, Johnson GL. MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis. Mol Cell Biol 1998;18:2416-29.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
